Featured Research

from universities, journals, and other organizations

Cancer-targeting virus delivered by IV is successful in treating advanced cancers, research finds

Date:
May 24, 2010
Source:
American Society of Gene & Cell Therapy
Summary:
Intravenous delivery of a cancer-targeting virus is successful in destroying cancer cells that have spread throughout the body, according to new research.

Intravenous delivery of a cancer-targeting virus is successful in destroying cancer cells that have spread throughout the body, according to research to be presented at the American Society of Gene & Cell Therapy 13th Annual Meeting.

A recent study tested 23 patients with metastasized colorectal, skin, ovarian and lung cancers. Patients received a single intravenous treatment at one of five dose levels. In 75 percent of patients who received the highest doses, the therapy reached and replicated within tumors throughout the body, effectively stopping cancer growth. Some patients on the lower doses also saw disease stabilization.

All dose levels were well tolerated, with patients experiencing only mild side effects, such as flu-like symptoms.

“This is the first time that we’ve been able to treat patients intravenously and had proven success in targeting and destroying metastatic cancers in the body with an armed oncolytic virus product,” said David H. Kirn, MD. “This opens up a whole new world of systemic approaches to therapy.”

Gene therapy has been used before to fight cancer, but previous treatments were limited to localized tumors. Intravenous delivery allows for whole-body treatment.

Kirn said the study opens the door to retest existing genetic or protein treatments that had previously been limited to patients with localized tumors. Researchers will begin a Phase III trial later this year in patients with liver cancer.


Story Source:

The above story is based on materials provided by American Society of Gene & Cell Therapy. Note: Materials may be edited for content and length.


Cite This Page:

American Society of Gene & Cell Therapy. "Cancer-targeting virus delivered by IV is successful in treating advanced cancers, research finds." ScienceDaily. ScienceDaily, 24 May 2010. <www.sciencedaily.com/releases/2010/05/100524105050.htm>.
American Society of Gene & Cell Therapy. (2010, May 24). Cancer-targeting virus delivered by IV is successful in treating advanced cancers, research finds. ScienceDaily. Retrieved October 2, 2014 from www.sciencedaily.com/releases/2010/05/100524105050.htm
American Society of Gene & Cell Therapy. "Cancer-targeting virus delivered by IV is successful in treating advanced cancers, research finds." ScienceDaily. www.sciencedaily.com/releases/2010/05/100524105050.htm (accessed October 2, 2014).

Share This



More Health & Medicine News

Thursday, October 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pregnancy Spacing Could Have Big Impact On Autism Risks

Pregnancy Spacing Could Have Big Impact On Autism Risks

Newsy (Oct. 1, 2014) A new study says children born less than one year and more than five years after a sibling can have an increased risk for autism. Video provided by Newsy
Powered by NewsLook.com
Ebola Patient Told Hospital He Was from Liberia

Ebola Patient Told Hospital He Was from Liberia

AP (Oct. 1, 2014) The first Ebola patient diagnosed in the U.S. initially went to a Dallas emergency room last week but was sent home, despite telling a nurse that he had been in disease-ravaged West Africa, the hospital acknowledged Wednesday. (Oct. 1) Video provided by AP
Powered by NewsLook.com
Robotic Hair Restoration

Robotic Hair Restoration

Ivanhoe (Oct. 1, 2014) A new robotic procedure is changing the way we transplant hair. The ARTAS robot leaves no linear scarring and provides more natural results. Video provided by Ivanhoe
Powered by NewsLook.com
Insertable Cardiac Monitor

Insertable Cardiac Monitor

Ivanhoe (Oct. 1, 2014) A heart monitor the size of a paperclip that can save your life. The “Reveal Linq” allows a doctor to monitor patients with A-Fib on a continuous basis for up to 3 years! Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins